PBF509, an Adenosine A2A Receptor Antagonist With Efficacy in Rodent Models of Movement Disorders

Adenosine A2A receptor (A2AR) antagonists have emerged as complementary non-dopaminergic drugs to alleviate Parkinson's disease (PD) symptomatology. Here, we characterize a novel non-xhantine non-furan A2AR antagonist, PBF509, as a potential pro-dopaminergic drug for PD management. First, PBF50...

Full description

Saved in:
Bibliographic Details
Main Authors: Fabiana Núñez (Author), Jaume Taura (Author), Juan Camacho (Author), Marc López-Cano (Author), Víctor Fernández-Dueñas (Author), Naomi Castro (Author), Julio Castro (Author), Francisco Ciruela (Author)
Format: Book
Published: Frontiers Media S.A., 2018-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available